AI solutions in healthcare under Drug Safety: AI‑Powered Counterfeit Detection help identify falsified or substandard medicines across manufacturing, distribution, and supply chain stages. These tools use image recognition, packaging analysis, and data pattern detection to verify product authenticity and trace provenance. Evaluation commonly focuses on detection accuracy, interoperability with existing track‑and‑trace systems, real‑world scalability, and compliance with global pharmacovigilance and supply chain security regulations.
Browse the AI tools below to identify the Drug Safety: AI-Powered Counterfeit Detection solutions that best match your data, workflow, and governance requirements.
This category page is for informational purposes only and does not constitute regulatory, clinical, or investment advice; organisations should conduct their own technical, legal, and governance due diligence before selecting any AI solutions in healthcare.
Counterfeit medicines can evade conventional checks, putting patients, brands and supply chains at risk. So which AI tools are best equipped to detect suspicious products before they cause harm?
Read the full comparison to explore the leading AI-powered approaches to counterfeit detection, hidden-brand analysis and pharmaceutical supply-chain protection.
For global pharmaceutical companies trying to stop counterfeit medicines online, the tools on this page are most useful as the authentication and evidence layer of a wider anti-counterfeit programme. Systech UniSecure, AlpVision, and Digimarc are strongest for protecting authentic packaging; TrueMed, VRAI AI, Cypheme, and RxScanner can help investigators, customs teams, pharmacies, or field personnel screen suspected physical products; and Thermo Fisher TruScan supports material-level screening with handheld Raman analysis.
For solutions focused specifically on finding and removing counterfeit medicine listings, fake pharmacy sites, impersonation, and unauthorised sellers across digital channels, see the Online Brand Protection & Counterfeit Enforcement category. It covers AI-powered platforms designed for web-scale monitoring, investigation, evidence collection, and takedown workflows for global pharmaceutical brands.
For pharmaceutical products, prioritise an AI-powered anti-counterfeiting tool that combines pack-level authentication, traceability, and evidence-led investigation. Not image detection alone. Essential capabilities include barcode, QR code, serial number, label, packaging, hologram, and image analysis; detection of altered or duplicated packs; and integration with track-and-trace, serialisation, ERP, warehouse, and pharmacovigilance workflows.
The platform should provide real-time risk scoring, case management, audit trails, evidence capture, alerts, dashboards, and escalation workflows for product-security, quality, legal, and patient-safety teams. Validate performance against genuine packs, known counterfeits, poor-quality images, damaged packaging, and target-market conditions before deployment.
For EU medicines, assess support for end-to-end verification of the unique identifier and anti-tampering device. These are required safety features for many prescription medicines and form part of the EU medicines-verification system.
Also confirm data governance, mobile/offline capability, global scalability, API access, implementation support, and whether the vendor can document detection accuracy, false-positive handling, and evidence of regulatory readiness.
